Profiling of Radiological Factors in Treatment and Outcomes in Prostate Cancer

Recruiting Observational Study
Prostatic Cancer Prostatic Neoplams Prostatic Hyperplasia Prostate Cancer Cancer Of Prostate
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Male
Study type
Observational
Participants needed
10,000 (estimated)
Sponsor
National Cancer Institute (NCI) · NIH
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Background: Prostate cancer is one of the most common cancers for men in the U.S. There are some new ways to take pictures of the cancer. There are also new ways to use image-guided biopsy and therapy. These could help manage prostate cancer. Researchers want to study how imaging can provide a profile of prostate cancer. They want to collect data to make diagnosis and treatments better. Objectiv…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
* INCLUSION CRITERIA: * Patients with an increased risk for prostate cancer (strong family history and/or germline mutation in DNA repair genes), or with a diagnosis of prostatic cancer or suspicious for prostatic cancer lesions. * Age greater than or equal to 18 years * Ability of subject to unders…
Contacts

Yolanda L McKinney, R.N.

(240) 760-6095

ymckinney@mail.nih.gov

CONTACT

Ismail B Turkbey, M.D.

(240) 760-6112

turkbeyi@mail.nih.gov

CONTACT